Gelnique and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Gelnique (oxybutynin chloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Singulair, and have Hypertonic bladder.

The phase IV clinical study analyzes which people have Rashes when taking Gelnique. It is created by eHealthMe based on reports of 350 people who have side effects when taking Gelnique from the FDA, and is updated regularly.

What is Gelnique?

Gelnique has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 370 Gelnique users. Check the latest studies of Gelnique.

What is Rashes?

Rashes (redness) is found to be associated with 3,713 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 13, 2026

350 people reported to have side effects when taking Gelnique.
Among them, 12 people (3.43%) have Rashes.

Among these 12 people:

How long have people been on Gelnique when they have Rashes? *

What is the gender of people who have Rashes when taking Gelnique? *

female: 100 %
male: 0.0 %

What is the age of people who have Rashes when taking Gelnique? *

What are other drugs people take besides Gelnique? *

Biotin: 2 people, 16.67%
Singulair: 2 people, 16.67%
Zolpidem: 1 person, 8.33%
Hydrocodone Bitartrate And Acetaminophen: 1 person, 8.33%
Lysine: 1 person, 8.33%
Lidocaine Viscous: 1 person, 8.33%
Keflex: 1 person, 8.33%
Januvia: 1 person, 8.33%
Invanz: 1 person, 8.33%
Imdur: 1 person, 8.33%

What are other side effects people have besides Rashes? *

Itching: 4 people, 33.33%
Fatigue (feeling of tiredness): 2 people, 16.67%
White Blood Cell Count Decreased: 1 person, 8.33%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 8.33%
Alanine Aminotransferase Increased: 1 person, 8.33%
Application Site Rash: 1 person, 8.33%
Aspartate Aminotransferase Increased: 1 person, 8.33%
Blood Alkaline Phosphatase Increased: 1 person, 8.33%
Chest Pain: 1 person, 8.33%
Chills (felling of cold): 1 person, 8.33%

What are the existing conditions these people have? *

Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 5 people, 41.67%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 16.67%
Hypersensitivity: 2 people, 16.67%
Urinary Tract Infection: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
Bladder Spasm: 1 person, 8.33%
Blood Glucose Increased: 1 person, 8.33%
Bone Disorder: 1 person, 8.33%
Breast Cancer Metastatic: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Gelnique and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gelnique:

Gelnique (370 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Gelnique:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,713 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin chloride (the active ingredients of Gelnique) and Gelnique (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.